Tuesday, 9 October 2018

Event Management Software Market to expand at a steady CAGR of 12.1% by 2026

Companies have begun the usage of event management software as it helps in improving the efficiency of the events business. The significant features of this software helps in powering successful events for industries as well as organizations of all sizes.

Global Market for Event Management Software: Dynamics Influencing Revenue Growth
With regards to revenue, the software segment is the most significant segment in the global event management software market and is projected to attain a market value of greater than US$ 5,000 Mn in 2017. Apart from this, software segment is expected to display substantial revenue growth owing to the increase in the adoption of professional services by corporate companies. The improved benefits of event management software is the key factor enhancing the adoption as well as growth of the software segment over the predictable period.
Social media platforms are turning out to be the most popular way for promoting as well as marketing events, social causes, campaigns, etc. The registration process is supported by software segment and people who visit the particular page on Facebook will be provided with e-ticket on their smartphone by the event management software. The e-ticket just has to be shown in the venue and entry will be given soon after the formalities of payment is done, which is either through cash or online payment. The ease and convenience of this process is also an important factor that eventually drives the market. Additionally, increase in the adoption of cloud-based solutions due to ease in accessibility and cost-efficiency is also aiding to the growth of software segment. All of these factors together are producing robust development in the global market for event management software’s software segment.


Taxonomy of Global Market for Event Management Software
The segmentation of the global market for event management software is done on the basis of enterprise type, deployment type, component type, industry type as well as region.

On the basis of enterprise type, the global market for event management software is segmented into large, medium and small enterprise. On the basis of deployment type, the global market for event management software is segmented into cloud and on-premise. Depending on the component type, the global market for event management software is segmented into software and services. Based on the sub-segment, software is segmented further into analytics and reporting, venue management, event marketing, event planning and others. Based on the sub-segment, services is segmented further as managed services and professional services. On the basis of industry type, the global market for event management software is segmented into travel and hospitality, education, government, event planner, corporate and others. On the basis of region, the global market for event management software is segmented into MEA, Japan, APEJ, Eastern Europe, Western Europe, Latin America and North America.

Regional Analysis
The market for event management software in North America is expecting that revenue from its software segment to upsurge at a reasonably high CAGR throughout the forecast period. Also, in this segment, the sub-segment namely event planning, is projected to upsurge at a high revenue CAGR throughout the forecast period. In Latin America, the sub-segment namely professional services is expected to expand at a high revenue CAGR throughout the projected period. In APEJ region, due to increase in the adoption of event marketing and venue management solutions, the software segment’s revenue is anticipated to upsurge at a high CAGR. The market for event management software in MEA is expecting that revenue from its software segment to upsurge at a reasonably high CAGR. This expectation is based on increase in the adoption of software for online event organizing, online registration, event planning and others.

Request to view Table of Content @: https://www.futuremarketinsights.com/askus/rep-gb-1849

Competition Landscape of Global Market for Event Management Software
The extensive research report on the global market for event management software covers analysis on the major companies active in the global market for event management software. Key companies such as SocialTables, EventZilla, Gather Technologies Inc., Certain, Inc., Zerista, Ungerboeck Software International, Bizzabo Inc., EventBrite Inc., etouches Inc., Zoho Corporation, Cvent, Inc., and Xing Events are profiled in this research report.

Diabetes segment market revenue share projected to grow at a significant CAGR owing to increasing prevalence of diabetes in Asia Pacific and MEA regions

Differential and innovative product strategies that are adopted by various multinational pharma companies have been fuelling the growth of branded generics market at a global scale. These strategies include establishing sustained local capabilities with the strong local talents, engaging in portfolio marketing, recalibrating regulatory affairs, bolstering sales force with the multi-channel engagement and enhancing contracting capabilities. Developing regions are witnessing a rapid increase in demand for branded generics on account of increasing affordability of the products and ease of regulations. Rising disposable income and changing lifestyle of consumers is also expected to augur well for growth of the branded generics market in the near future.



The study predicts that patent expiries of the blockbuster drugs are likely to create demand for branded generics during the forecast period. Increasing prevalence of the lifestyle and chronic diseases such as cardiovascular diseases and diabetes together with increasing purchasing power makes branded generics market attractive for investors. The study by Future Market Insights predicts that branded generics market is likely to register a healthy 7.3% CAGR over the forecast period, 2016-2026. Commodity generic products and huge competition from the branded drugs have prevailed as major challenges inhibiting the growth of branded generics market, in terms of price structure.


Cardiovascular Diseases are likely to prove highly lucrative for revenue growth of branded generics market due to rising prevalence of diverse types of cancers and increasing comorbidities across the globe. Anti-hypertensive segment is expected to prove highly lucrative for the purpose of reducing premature cardiovascular disease. Oral formulations hold the largest demand from medical providers and patients for branded generics. This is mainly due to the benefits that oral formulation offers such as accuracy, dosing convenience and easy adherence to a medication plan.
Parenteral formulations are likely to gain traction in branded generics market during the forecast period, with API (active pharmaceutical ingredient) being degraded in intestinal tracts, thereby driving the demand for parenteral delivery. The report predicts that APEJ and North America are likely to remain lucrative for parenteral formulations during the forecast period. Retail Pharmacies are expected to prove as the most lucrative distribution channel for branded generics, as the pharmaceutical companies’ manufacturers are highly dependent on this distribution channel for selling the products over-the-counter.

APEJ accounts for the largest revenue share in the branded generics market owing to lack of worldwide health coverage and higher out-of-the-pocket expenditure on healthcare. China, India and ASEAN countries are expected to pose lucrative growth opportunities for the new and existing key players in the forthcoming years. Most of the leading manufacturers in the global market are concentrated in Asian countries and have been working towards expansion of their production capacity, for catering to the existing and emerging global demands.

Statutory regulatory bodies have been playing a significant role in the growth branded generics market in APEJ by providing approvals for products. Furthermore, growth through the adoption of inorganic approaches have been forming cornerstone of the branded generics drug makers in APEJ region. Latin America, Eastern Europe and North America will prove significantly lucrative for the branded generics market in the forthcoming years.

Request to view Table of Content @: https://www.futuremarketinsights.com/askus/rep-gb-1260

Brand-name prescriptions are anticipated to remain ubiquitous amongst the aged people worldwide. Since geriatric demographics hold a larger portion of drug-consuming population across the globe, demand for branded generics are expected to rise substantially. Branded generics market has been projected to develop at a healthy pace as enormous number of the pharmaceutical products are expected to go off-patent within the assessment period of 2016-2026.

Thursday, 4 October 2018

Pharmaceutical Filtration Market Would Reach US$ 17 billion by 2022

Active pharmaceutical ingredients are a key component of the pharmaceutical industry in the 21st century. Filters are essential in a number of cases during the course of API creation and are necessary in bioscience laboratory applications as well. An increased production of large biologics and molecules, nano fibre technological advancements, generic market growth, and regulatory guidelines for cleanroom pharmaceutical production are the main factors driving the pharmaceutical filtration market. Additional funds diverted towards R&D expenditure by major biopharmaceutical organizations also boost the profile of the pharmaceutical filtration market. According to Future Market Insights, the pharmaceutical filtration market is expected to record a robust CAGR of 6.1% for the period from 2017 to 2022.


  • Manufacturing has the major portion of the revenue share in the pharmaceutical filtration market by operation in 2017 and is likely to remain so throughout the duration of the forecast period. The manufacturing segment is expected to cross a value of more than US$ 9.3 billion by end 2022 making it imperative for companies to be present in this operation segment of the pharmaceutical filtration market. The pilot scale segment follows at a considerable distance but cannot be overlooked entirely in favour of manufacturing. The pilot scale filtration segment has strong scope in North America as the continent represents a little over a third of the pharmaceutical filtration market and is estimated to retain this share going forward
Request for sample copy of report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-5028
  • The cell separation segment comprises slightly above a sixth of the pharmaceutical filtration market by application and is predicted to lose popularity in the future. Nonetheless, the North America cell separation market alone is on track to push past a billion dollars by end 2022 and companies are advised to take this into account while devising their business strategies. The water purification segment has a similar revenue share to the cell separation segment in the pharmaceutical filtration market by application. After North America, the water purification segment is particularly prominent in Europe
  • In terms of technology, microfiltration is quite popular as it contributes nearly half the revenue share in the pharmaceutical filtration market in the year 2017. Furthermore, microfiltration is anticipated to witness a high CAGR of more than 5.5% for the period 2017-2022 ensuring that all key stakeholders have ample opportunity in this lucrative technology. Ultrafiltration is not as prominent as microfiltration in the pharmaceutical filtration market but is gaining traction recently. Ultrafiltration technology has the greatest scope in both North America and Europe as these two continents are projected to cross a billion dollars in terms of value by end 2022
  • North America is the largest region in the pharmaceutical filtration market and is poised to grow to more than US$ 6 billion by end 2022
Request to view Table of Content @: https://www.futuremarketinsights.com/askus/rep-gb-5028

  • The report has profiled a few of the companies in the pharmaceutical filtration market. These include The Marmon Group LLC, Sartorius Stedim Biotech, Meissner Filtration Products, Parker Hannifin Corporation, Pall Corporation, Merck KGaA, GE Healthcare Inc., Eaton Corporation Plc., Amazon Filters Ltd., and 3M Companies.